» Articles » PMID: 35638753

Diagnostic Accuracy of Fluorescence Flow-cytometry Technology Using Sysmex XN-31 for Imported Malaria in a Non-endemic Setting

Abstract

Malaria diagnosis based on microscopy is impaired by the gradual disappearance of experienced microscopists in non-endemic areas. Aside from the conventional diagnostic methods, fluorescence flow cytometry technology using Sysmex XN-31, an automated haematology analyser, has been registered to support malaria diagnosis. The aim of this prospective, monocentric, non-interventional study was to evaluate the diagnostic accuracy of the XN-31 for the initial diagnosis or follow-up of imported malaria cases compared to the reference malaria tests including microscopy, loop mediated isothermal amplification, and rapid diagnostic tests. Over a one-year period, 357 blood samples were analysed, including 248 negative and 109 positive malaria samples. Compared to microscopy, XN-31 showed sensitivity of 100% (95% CI: 97.13-100) and specificity of 98.39% (95% CI: 95.56-100) for the initial diagnosis of imported malaria cases. Moreover, it provided accurate species identification asfalciparumor non-falciparumand parasitaemia determination in a very short time compared to other methods. We also demonstrated that XN-31 was a reliable method for patient follow-up on days 3, 7, and 28. Malaria diagnosis can be improved in non-endemic areas by the use of dedicated haematology analysers coupled with standard microscopy or other methods in development, such as artificial intelligence for blood slide reading. Given that XN-31 provided an accurate diagnosis in 1 min, it may reduce the time interval before treatment and thus improve the outcome of patient who have malaria.

Citing Articles

evaluation of the automated hematology analyzer XN-31 for rapid diagnosis of equine piroplasmosis.

Ochi A, Toya Y, Sengoku M, Tsuchiya S, Kishi D, Ueno T Microbiol Spectr. 2024; 12(10):e0058224.

PMID: 39269182 PMC: 11448420. DOI: 10.1128/spectrum.00582-24.


Diagnostic role of Sysmex hematology analyzer in the detection of malaria: A systematic review and meta-analysis.

Mulatie Z, Kelem A, Chane E, Mekuanint Tarekegn A, Teketelew B, Yenesew A PLoS One. 2024; 19(9):e0296766.

PMID: 39240990 PMC: 11379208. DOI: 10.1371/journal.pone.0296766.


Digital microscopy and artificial intelligence could profoundly contribute to malaria diagnosis in elimination settings.

Beck H Front Artif Intell. 2022; 5:510483.

PMID: 36467561 PMC: 9713510. DOI: 10.3389/frai.2022.510483.


Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan.

Komaki-Yasuda K, Kutsuna S, Kawaguchi M, Kamei M, Uchihashi K, Nakamura K Malar J. 2022; 21(1):229.

PMID: 35907857 PMC: 9338637. DOI: 10.1186/s12936-022-04247-x.

References
1.
Ponce C, Kaczorowski F, Perpoint T, Miailhes P, Sigal A, Javouhey E . Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic setting. Parasite. 2017; 24:53. PMC: 5734902. DOI: 10.1051/parasite/2017054. View

2.
Britton S, Cheng Q, McCarthy J . Novel molecular diagnostic tools for malaria elimination: a review of options from the point of view of high-throughput and applicability in resource limited settings. Malar J. 2016; 15:88. PMC: 4754967. DOI: 10.1186/s12936-016-1158-0. View

3.
Tougan T, Suzuki Y, Izuka M, Aono K, Okazaki T, Toya Y . Application of the automated haematology analyzer XN-30 in an experimental rodent model of malaria. Malar J. 2018; 17(1):165. PMC: 5902832. DOI: 10.1186/s12936-018-2313-6. View

4.
Buderer N . Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996; 3(9):895-900. DOI: 10.1111/j.1553-2712.1996.tb03538.x. View

5.
Dubreuil P, Pihet M, Cau S, Croquefer S, Deguigne P, Godon A . Use of Sysmex XE-2100 and XE-5000 hematology analyzers for the diagnosis of malaria in a nonendemic country (France). Int J Lab Hematol. 2013; 36(2):124-34. DOI: 10.1111/ijlh.12145. View